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ABSTRACT 
Diabetic retinopathy (DR) a major consequence of diabetes is considered the leading 
cause of vision loss and blindness worldwide among working adults. Endothelial 
dysfunction expediting imbalance in vascular homeostasis, is one of the primary 
manifestation leading to the pathogenesis of DR. NO a major vasodilator involved in the 
regulation of vascular homeostasis is reported to be released by insulin dependent PI3K/ 
Akt signaling pathway. Endothelial dysfunction impairs ocular hemodynamics by 
reducing the bioavailability of NO and increasing the production of reactive oxygen 
species (ROS) and may be responsible for the pathogenesis of vascular dysfunction in 
retinopathy.  
In the current study in order to examine the effect of insulin on NO production, HRECs 
cells were cultured and grown in high glucose (30mM) and normal (5mM) glucose  for 
24 hours. Subsequently, the cells were treated with 100nM insulin for 10 minutes, 1, 2, 
and 4 hours. The various parameters of PI3K/ Akt signaling pathway were analyzed.  
This study demonstrated that Hyperglycemia causes an increase in ROS/oxidative stress 
and apoptosis, while insulin promotes a significant decrease in ROS and apoptosis, eNOS 
mediated NO production increases with hyperglycemia but remarkably reduced with 
insulin treatment after 1hour, 2 hours and 4 hours. This may suggest that insulin  could 
counteract the hyperglycemic effect on AKT/PI3 kinase which mediates NO production 
and VEGF-A, with decreased adhesion molecules such as p-selectin that is involved in 
barrier disorder of retinal endothelial cells. In summary, insulin could counteract the 
deleterious effects of hyperglycemia on retinal endothelial cells via various molecular 
approach including oxidative stress, apoptosis, NO, and adhesion molecules. 
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INTRODUCTION 
Obesity and type 2 diabetes is characterized by insulin resistance which has been reported 
as the major risk factors associated with the development of the endothelial dysfunction 
and vascular complications such as atherosclerosis. Induction of the vascular dysfunction 
is obviously a proved metabolic consequence of insulin resistance.  
Diabetes leads to altered retinal microvascular function and ultimately diabetic 
retinopathy. Insulin signaling may play a role in this process, and animal studies 
indicated a role of the insulin in the pathogenesis of retinal neovascularization through its 
effect on endothelial cells. Endothelial dysfunction impairs ocular hemodynamics by 
reducing the bioavailability of NO and increasing the production of reactive oxygen 
species (ROS) and may be responsible for the pathogenesis of vascular dysfunction in 
retinopathy. Nitric oxide (NO) well known to play a significant role in the cardiovascular 
systems functions is reported to be released through the insulin stimulated PI3K/Akt 
signaling pathway. Several factors are postulated to be associated with the reduced 
production of NO of the vascular endothelium in inulin–resistant states such as 
impairment of eNOS production, and PI3K activation. 
Insulin resistance would impair the production of  NO in retinal vascular endothelial 
cells. Until now, the pathophysiology of retinal vascular dysfunction due to high glucose 
load and insulin resistance in association with NO bioavailability in these cells remains 
unclear. This study was thus designed in the interest to elucidate the correlation between 
hyperglycemia and insulin resistance in human retinal microvascular endothelial cells.  
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HYPOTHESIS 
In diabetic arteries, endothelial dysfunction seems to involve both insulin resistance 
specific to the Akt pathway and hyperglycemia. Hyperglycemia itself also inhibits 
production of nitric oxide in arterial endothelial cells. We hypothesize that hyperglycemia 
and insulin resistance would impair NO production in human retinal endothelial cells. 
 
AIMS AND OBJECTIVES 
The primary objective of this research is to elucidate the potential role of insulin and its 
signaling pathway on NO synthesis on the human retinal microvascular endothelial cells 
(HRECs) exposed to high glucose load to induce insulin resistance.  
In order to achieve the general aim, the study had the following endpoints: 
1) Assess the production of NO in the condition medium and the cell lysate 
2) Assess the expression of endothelial NO synthase (eNOS) 
3) Assess the insulin signaling pathway at the protein levels and phosphorylation of: 
IRS1. 
4) Assess the expression of angiogenic, adhesion molecules and inflammatory 
markers : VEGFA,  P-Selectin and NFkB.  
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1.LITERATURE REVIEW: 
1.1 Diabetes 
Diabetes is characterized by the persistent increase in blood sugar levels (hyperglycemia). 
It occurs as a consequence of inadequate production of insulin, known as type 1 diabetes, 
or in association with obesity and metabolic syndrome, known as type 2 diabetes resulting 
from resistance to endogenous insulin (Favero, Paganelli, Buffoli, Rodella, & Rezzani, 
2014). Impaired endothelial functions in diabetes could aid the reduction in insulin 
availability to the tissue; thus decreasing insulin sensitivity independently from its direct 
effector ions in the muscle cells (Kolka & Bergman, 2013). Endothelial impairment, in type 
I diabetes are preponderantly reported to be caused by metabolic changes mainly at retinal 
and kidney levels by hyperglycemia and microvascular complications (Giacco & Brownlee, 
2010). Contrary to this  in type 2 diabetes, the association between endothelial dysfunction 
and diabetes are depicted as more complex, due to the initiation of  endothelial dysfunction 
well before the onset of diabetes(Caballero et al., 1999). Type 2 diabetes is characterized 
by insulin resistance that has been reported as the major risk factor associated with the 
development of endothelial dysfunction and vascular complications such as atherosclerosis. 
1.2 Epidemiology  
Diabetic retinopathy (DR) a major impediment of diabetes is considered the leading cause 
of vision loss and blindness worldwide among working adults. According to the World 
Health Organization (WHO)("World Health Organization," 2015), the global prevalence of 
diabetes in 2014 had been estimated to be 9% among adults aged 18 years and above. As 
updated in November 2014, diabetes has been foreseen to become the 7th leading cause of 
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death worldwide by the year 2030 ("World Health Organization," 2015). Presently of the 
347 million people worldwide enduring diabetes, approximately10% have a severe visual 
impairment, and  2% become blind (World Health Organization , 2015). Reckoned as a 
multifactorial progressive retinal disease DR, abides an extremely complex pathogenesis 
involving many different cells, molecules, and factors. The dilapidating  consequences of 
diabetes results in the impairment of major retinal cells including Muller, pigment 
epithelial, ganglion as well as endothelial cells (Cheung, Mitchell, & Wong, 2010). 
1.3 The vascular endothelium 
The vascular endothelium consists of a thin layer of  cells lining the lumen of the blood 
vessels that plays a vital role in maintaining homeostatic processes. It bestows a physical 
barrier between the blood vessel wall and the lumen (Wheatcroft, Williams, Shah, & 
Kearney, 2003). Endothelium secretes a number of mediators that instigate the control of 
vascular tone, transacting blood and nutrients into and out of the blood stream, vascular 
permeability, vasculogenesis, and angiogenesis (Cines et al., 1998; Pries & Kuebler, 
2006; D. Y. Yu, Yu, Cringle, Kang, & Su, 2014). Figure1.1 briefly illustrates the major 
function of the vascular endothelium. 
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Vascular tone is modulated by the production and release of various vasodilator and 
vasoconstrictor mediators. Endothelial derived vasodilators include nitric oxide (NO), 
prostacyclin (PGI2) and endothelium-derived hyperpolarizing factor (EDHF); whereas 
vasoconstrictors include endothelin-1 and thromboxane A2 (Wheatcroft, Williams, et al., 
2003; D. Y. Yu et al., 2014). Retinal arterioles belong to the category of small resistance 
arterioles requiring an exquisite balance between vasodilator and constrictor influences. 
This balance is crucial in order to appropriately adjust to various factors such as shear 
stress, temperature changes and blood volume variations (D. Y. Yu et al., 2014). 
Figure1.1. Frame grabbed image of an isolated perfused porcine retinal artery. 
Five major functions are schematically illustrated. These functions collectively 
serve to regulate vascular supply to tissues. Endothelial dysfunction plays  crucial 
roles in the pathology of vascular failure. (D. Y. Yu, Yu, Cringle, Kang, & Su, 
2014) 
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Endothelial dysfunction is defined as a flawed  release of endothelium-mediated 
vasodilators along with disarticulated endothelial adhesion molecules and chemokines 
expression. Oxidative stress, diabetes and insulin resistance are among the multitude of 
pathogenic stimuli that impel vascular endothelial dysfunction. In many systemic 
diseases and retinal diseases, oxidative stress is considered an important initial 
pathogenic step leading to retinal ischemic disease, diabetic retinopathy,  inflammation 
and glaucoma (Bharadwaj et al., 2013).  
 
1.4 Nitric oxide production in vascular endothelium 
1.4.1 Nitric oxide synthases 
Nitric oxide synthases (NOS) are three distinct set of isoforms that catalyzes the synthesis 
of nitric oxide from L-arginine. Products of three different genes located on 
chromosomes 7,17 and 12; NOS isoforms are endothelial (eNOS, or NOS III), neuronal 
(nNOS, or NOS I) and inducible NOS (iNOS, or NOS II) (Alderton, Cooper, & Knowles, 
2001; Andrew & Mayer, 1999). Activation of nNOS and eNOS via the 
calcium/calmodulin complex leads to the production of nitric oxide (NO). However, 
contrary to this iNOS are generated in the presence of immunological and inflammatory 
stimuli (Schmetterer & Polak, 2001).  The enzymatic activity of NOS requires oxygen, 
nicotinamide adenine dinucleotide phosphate (NADPH) and essential cofactors flavin 
mononucleotide (FMN), falvin adenine dinucleotide (FAD), haem and 
tetrahydrobiopterin (BH4) for NO generation (Kearney et al., 2008). 
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1.4.2 eNOS 
eNOS being the principal source of endothelial NO is of preeminent importance for the 
normal vascular system functioning. It is activated by both hormonal factors such as 
insulin (Kearney et al., 2008; Sobrevia, Nadal, Yudilevich, & Mann, 1996), vasopressin 
(Kearney et al., 2008; Resta, Gonzales, Dail, Sanders, & Walker, 1997), cytokines 
(Yoshizumi, Perrella, Burnett, & Lee, 1993) and mechanical forces such as sheer stress 
created due to blood flow through blood vessels (Dimmeler et al., 1999).  In vitro studies 
reports indicated the induction of  eNOS serine phosphorylation by shear stress, vascular 
endothelial growth factor (VEGF) and insulin through phosphatidylinositol-3 kinase 
(PI3K) pathway followed by downstream protein kinase Akt (Protein kinase B) 
phosphorylation. These in turn enhance NO synthesis without the use of 
calcium/calmodulin complex pathway (Dimmeler et al., 1999; Toda & Nakanishi-Toda, 
2007).  
1.4.3 Nitric Oxide production 
eNOS stimulated NO production regulation is a complex process. eNOS is reported to be 
stimulated by two mechanisms either in a calcium dependent manner or in calcium 
independent manner. L-arginine when transformed through NG-hydroxy-L-arginine to L-
citrulline due to the catalysis of NOS in the presence of oxygen and cofactors leads to NO 
production (Toda & Nakanishi-Toda, 2007). 
1.4.4 Insulin stimulated NO production 
Earlier works demonstrate NO production in a cultured endothelial cell under the 
influence of wortmannin-sensitive stimulation leading to insulin directed vasodilation. 
Various studies have established that though eNOS is constitutively expressed; both shear 
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stress and insulin are reported to elevate endothelial NO production through the 
phosphorylation of PI3K and activated Akt leading to eNOS phosphorylation (Salt, 
Morrow, Brandie, Connell, & Petrie, 2003; Scherrer, Randin, Vollenweider, 
Vollenweider, & Nicod, 1994).  
Independent in vitro studies conducted on bovine aortic endothelial cells (BAECs) (Kim, 
Gallis, & Corson, 2001; Montagnani, Chen, Barr, & Quon, 2001), human umbilical vein 
endothelial cells (HUVEC) (Zeng & Quon, 1996), and kidney collecting duct cells 
(Pandey et al., 2015) proposed rapid insulin-receptor substrate-1 (IRS-1) or IRS-2  
tyrosine phosphorylation following insulin stimulation. This was followed by IRS-1 
associated PI3K activation, in turn leading to  phosphorylation and activation of Akt, 
Ser1177 specific site eNOS phosphorylation, and NO production. Figure1.2. Below 
illustrates insulin stimulated endothelial cell NO release and vasodilatation. 
  
 
 
 
 
 
 
 
 
 
 Figure 1.2.Insulin and endothelial cell NO release(Kearney, Duncan, 
Kahn, & Wheatcroft, 2008) 
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1.4.5 Other eNOS products  
Compelling studies proclaim eNOS can directly or indirectly catalyze compilation of 
reactive oxygen species (ROS) within the vascular wall. These include nitroxyl (NO-) 
ions, peroxynitrite (ONOO-), superoxide (O2- ) and nitrosothiols. Uncoupling of eNOS 
due to NADPH oxidation leads to increased vascular superoxide production (Griendling, 
Sorescu, & Ushio-Fukai, 2000). This process in turn decreases NO synthesis (Vásquez-
Vivar et al., 1998). Another major mechanism of eNOS uncoupling is depicted by BH4  
depletion or oxidation and converting it to its inactive form dihydrobiopterin(BH2), 
expediting superoxide production which decreases NO synthesis (Cosentino & Lüscher, 
1998; Mortensen & Lykkesfeldt, 2014). Superoxide upon reaction with NO form 
peroxinitrite and nitrate. Peroxinitrite may activate redox signaling cascades inducing 
endothelial destruction or in turn  may enhance O2-  production and reduced NO synthesis 
through further oxidation and uncoupling of eNOS (Zou, Shi, & Cohen, 2002). 
1.5 Role of Nitric Oxide  
NO as free radical acts primarily in an autocrine or paracrine fashion, due to its extremely 
short half-life of only 3-6 seconds (Mayer & Hemmens, 1997). NO once produced, 
activates soluble enzyme guanylyl cyclase that catalyzes the formation of cyclic 
guanosine monophosphate (cGMP) from guanosine triphosphate. At physiological 
concentrations NO result in the phosphorylation of multitude of molecules involved in 
the smooth muscle relaxation. This leads to cGMP stimulated vasodilation of endothelial 
cells (Gewaltig & Kojda, 2002; Toda & Nakanishi-Toda, 2007). Apart from vasodilation, 
endothelial NO induces a reduction in vascular resistance, reduces blood pressure, 
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interrupt platelet aggregation and adhesion, leukocyte adhesion and transmigration, 
prohibits smooth muscle cell proliferation and prevent atherosclerosis (Förstermann, 
2008, 2010).     
1.6  Insulin resistance and endothelial dysfunction 
Insulin resistance is defined as glucose-insulin homeostasis imbalance whereby, there is 
decreased glucose uptake in the peripheral tissues in response to insulin. Another factor 
closely related is hyperinsulinemia that occurs as a consequence of insulin resistance 
while both are risk factors for vascular disorders. Though insulin resistance is strongly 
associated with endothelial dysfunction yet, insulin resistance being the cause or result is 
disputed (Kearney et al., 2008; Wheatcroft, Williams, et al., 2003). An in vivo analysis of 
eNOS-knockout mice showed insulin resistance when compared to their wild-type 
counterparts. This indicates insulin resistance could be a maker in preference to the 
causative agent of endothelial dysfunction (Shankar, Wu, Shen, Zhu, & Baron, 2000). 
Clinical studies suggest insulin-resistant patients presenting increased circulating levels 
of endothelin-1 (ET-1), a potent vasoconstrictor. Vasodilators and vasoconstrictors 
balance is further aggravated due to the increased production of ET-1 following NO and 
ET-1 reciprocal activity. Studies have shown PI3K inhibition by ET-1 in smooth muscles 
exacerbating impaired vasodilation and endothelial dysfunction (Groop, Forsblom, & 
Thomas, 2005; Kalani, 2008). In a vivo study conducted on rats demonstrated ET-1 
stimulating increased NADPH oxidase-dependent ROS generation, which led to attenuate 
NO bioavailability. This further lead to endothelial dysfunction and increased 
vasoconstriction (Sánchez et al., 2014). 
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1.7 Insulin resistance and diabetic retinopathy 
Induction of the vascular dysfunction is actually a metabolic consequence of insulin 
resistance (Chakravarthy, Hayes, Stitt, McAuley, & Archer, 1998).  Diabetes leads to 
altered retinal microvascular function and ultimately diabetic retinopathy. The evidently 
reported causative agents encompassed in the pathophysiology of DR include factors like 
glucose, insulin, advanced glycation end products(AGE), lipids and lipoproteins, growth 
factors and cytokines such as vascular endothelial growth factor (VEGF), insulin like 
growth factor (IGF), intracellular mediators such as phosphatidylinositol 3 kinase(PI3K), 
protein kinase C (PKC), vasoactive substances such as nitric oxide (NO); oxygen free 
radicals such as superoxide anion radical (O2-) and various other factors (Ahsan, 2015; Ola 
et al., 2012). Disruption in metabolites within diabetic retina alters the production pattern of 
a number of mediators including growth factors, neurotrophic factors, 
cytokines/chemokines, vasoactive agents, inflammatory molecules, coagulation factors, and 
adhesion molecules. These disruptions in turn prompt increased blood flow, increased 
capillary permeability, altered cell turnover (apoptosis), and finally angiogenesis (Ola et al., 
2012). Multitudinous investigative compilations suggest that the increment in fluxes 
attained via these pathways may lead to a cascade of events resulting in the induction of 
retinal damage leading to DR. These include the promotion of apoptosis, inflammation and 
angiogenesis. (Ola et al., 2012) 
During the early stages of the development  of diabetes, intracellular hyperglycemia causes 
abnormalities in blood flow and elevated vascular permeability. As a consequence this 
leads to decreased function of vasodilators such as nitric oxide, increased activity of 
vasoconstrictors such as angiotensin II and endothelin-1. This causes an increase in the  
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permeability factors such as vascular endothelial growth factor (VEGF).  Added up, these 
variations lead to edema, ischemia and hypoxia-induced neovascularization in the retina, 
proteinuria, mesangial matrix expansion and glomerulosclerosis in the  kidney, and 
multifocal axonal degeneration in peripheral nerves (Figure1.3). 
 
                  
1.8 Endothelial dysfunction and Biochemical Changes: 
Among the several reported signs of DR micro aneurysm and hemorrhages are denoted as 
early signs, while dilated, tormenting, irregular and narrow retinal blood vessels known as 
retinal ischemia are later signs that ultimately result in neovascularization (Chen, Liu, Xiao, 
& Lu, 2014; Gao, Zhu, Tang, Wang, & Ren, 2008). Earlier studies have reported 
hyperglycemia to be a contributing factor in retinal capillary damage and modifications in 
retinal hemodynamics, ensuing in hypoxia state and elevated tissue production  of 
Figure1.3.  Pathway to Consequences of Hyperglycemia (Alves, Carvalheira, Módulo, & 
Rocha, 2008).  
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angiogenic factors in both early and later stages of diabetic retinopathy by activation and 
dysregulation of many metabolic pathways (Gao et al., 2008).  High glucose concentrations 
within the cells could increase flux through the activation of various pathways such as 
glycolytic pathway, hexosamine pathways and stimulation of PKC and PI3K leading to 
increased ROS production, with the induction of oxidative stress, apoptosis, inflammatory 
response, and promotion of angiogenesis (Kowluru & Chan, 2007; Ola et al., 2012; 
Yamagishi & Matsui, 2011).  Several conflicting studies suggest that hyperglycemia may 
not be an inducer or contributor to the range of cellular and functional changes in the 
pathophysiology of DR (Kowluru, Abbas, & Odenbach, 2004).  
1.8.1  Insulin induction and VEGF expression  
Numerous growth factors and  cytokines have been entailed to play a role in the 
pathogenesis of retinal neovascular diseases. Previous studies account vascular endothelial 
growth factor (VEGF) to serve as a primary stimulator of capillary formation and enhanced 
cell permeability inducing the vascular pathology of diabetic retinopathy (Wu et al., 2010). 
Preclinical and clinical studies  have evinced intraocular VEGF elevation in the eyes of 
diabetic patients with blood-retinal barrier breakdown and neovascularization following 
injury triggered by oxygen stress and hyperglycemia (Wheatcroft, Kearney, et al., 2003). 
Lately, the VEGF  expression in numerous cell types such as fibroblast, epithelial cells and 
others have been stipulated to be increased in response to insulin; thereby amalgamated 
with the worsening of diabetic retinopathy following acute intensive insulin therapy (Zeng 
& Quon, 1996). The mode of VEGF expression though remain poorly understood has been 
reported to be regulated by numerous growth factors and cytokines, inclusive are 
interleukin 1-β, platelet-derived growth factor (PDGF) and transforming growth factor β. 
27 
 
(X. Du, Stocklauser-Färber, & Rösen, 1999). In vitro studies reportedly display insulin-
induced VEGF expression at normal glucose levels (5mM) to be mediated through the 
activation of phosphatidylinositol 3-kinase/Akt (PI-3K), a downstream element of the 
insulin receptor. In vitro studies in bovine retinal microvascular endothelial cells (BRECs)  
and Human umbilical vein endothelial cells (HUVEC) at 30mM glucose concentration 
mimicking hyperglycemic state (Wu et al., 2010) along with Human retinal endothelial 
cells (HREC) at 15mM and 25mM glucose concentration  have demonstrated an increase in 
VEGF expression(Gao et al., 2008).    
1.8.2 Insulin resistance and proinflammatory mediators  
Nuclear factor kappa B (NF-KB) is a nuclear transcription factor found in all cell 
types;(Patel & Santani, 2009)  known to be activated in response to stress, hypoxia, viral 
proteins, bacteria and proinflammatory cytokines stimulus (Mitamura et al., 2003). NF-kB 
activation has been demonstrated to be either anti- or proapoptotic based on the cell type 
and disease state. Nonetheless,  preclinical (Kowluru, Koppolu, Chakrabarti, & Chen, 
2003) and clinical studies (Kowluru & Chan, 2007; Romeo, Liu, Asnaghi, Kern, & 
Lorenzi, 2002), have exhibited proapoptotic activity in the retina and its capillary cells in 
diabetes-induced NF-kB activation. In vitro and in vivo studies have shown that rat 
endothelial cells incubated with high glucose concentrations to have retinal NF-kB 
activation and elevation by approximately 60% (Kowluru et al., 2003). Gene expression 
levels of NF-kB in the epiretinal membranes in conditions such as proliferative diabetic 
retinopathy is reported to be significantly increased in a study performed by Mitamura et al. 
This result was confirmed by immunohistochemistry analysis (Mitamura et al., 2003).  NF-
kB activation is reported to transform the expression of multiple proinflammatory factors 
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conjointly tumor necrosis factor and inducible nitric oxide synthase; in turn resulting in an 
increment in free radical production (Griscavage, Wilk, & Ignarro, 1996; Kowluru et al., 
2003). Kowluru et al. reported that high glucose following NF-kB activation lead to 
increase in oxidative stress and nitric oxide over 50% in the diabetic retinas of rats 
(Kowluru et al., 2003). However, the precise mechanism of NF-kB activation under 
hyperglycemia and insulin treatment consistent with diabetic retinopathy patient under 
treatment needs to be investigated.  
1.8.3 Endothelial dysfunction and cellular adhesion molecules 
Inflammatory cytokines are proclaimed to be upregulated in diabetic retinopathy with an 
evident increase in endothelial adhesion molecules such as ICAM1, VCAM1, PECAM-1 
and P-selectin (Matsumoto et al., 2002; McLeod, Lefer, Merges, & Lutty, 1995; 
Rangasamy, McGuire, & Das, 2012). This is followed by the emancipation of 
inflammatory chemokines, cytokines and vascular permeability factors thereby leading to 
amended endothelial cell adherence and tight junction proteins (Kamiuchi et al., 2002). 
Consequently these distortions further impact the pathogenesis and progression of DR.  
ICAM1 (Intercellular Adhesion Molecule 1) also known as CD 54 encoded by ICAM1 
gene are typically expressed on endothelial cells and immune system cells. ICAM1 though 
are continuously present in minimal concentration are reported to be upregulated upon 
cytokine stimulations. P-selectin also referred to as CD62P, the cell adhesion molecules 
though are expressed in megakaryocytes and endothelial; the expression levels are reported 
to be induced by inflammatory mediators (Ley et al., 1995; Rangasamy et al., 2012; 
Tedder, Steeber, Chen, & Engel, 1995). These adhesion molecules are proclaimed to play a 
focal portrayal in leukocyte adhesion to the endothelium amid inflammation and 
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pathogenesis of DR (Liu et al., 2005). Previous clinical comparative studies between 
normal, diabetic without retinopathy and DR patients evinced a significant increase in 
ICAM (Kamiuchi et al., 2002; Khalfaoui, Lizard, & Ouertani-Meddeb, 2008; McLeod et 
al., 1995; Penman et al., 2015).  
Various independent studies have reported an elevated plasma P-selectin levels among DR 
patients in African Americans (Penman et al., 2015) and white subjects (Sobrin et al., 
2011). The effect of the adhesion molecules ICAM1 and P-selectin at the level of retinal 
endothelial cells need to be elucidated for the better understanding of the DR pathogenesis 
under high glucose and insulin exposure though significant association has been found in 
cultured retinal glial cell at diabetic like high glucose concentration of 25mM(Melissa 
DeAnn Shelton, 2007). 
1.8.4 Endothelial dysfunction and angiogenesis impairment  
Two independent studies performed on HUVECs(P. Yu et al., 2006) and HREC(Chen et 
al., 2014) at 30mM glucose concentration demonstrated an increase in VEGF and PI3K-
Akt  pathway components at the mRNA levels assessed by reverse-transcription 
polymerase chain reaction(RT-PCR); furthermore the results were confirmed by protein 
expressions by western blot analysis. Cell migration through scratch wound assay 
investigated in both the studies at 5mM and 30mM medium glucose concentrations 
consistently evinced a significant decrease in the cell proliferation at a high glucose 
concentration in comparison to normoglycemia glucose concentrations. These studies 
denote high glucose as the rationale for alteration in PI3K and Akt signaling expediting 
into endothelial cell migration, proliferation and angiogenesis dysfunction.   
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1.8.5 Oxidative stress and apoptosis in endothelial dysfunction         
Diabetes and hyperglycemia reportedly induce oxidative stress in the retina and may play a 
pivotal role in the development of DR by damaging retinal cells (Nakagawa et al., 2006). 
Approximately 0.1%-5% of oxygen under normal physiological conditions, are recorded to 
enter the electron transport chain eventually been reduced to superoxide; a reactive oxygen 
species (ROS). The remnants of the oxygen are imputed to be utilized in metabolic 
processes(Kowluru & Chan, 2007). Expanding documentations emphasize oxidative stress 
having critical involvement in the pathogenesis of diabetes and DR.  Owing to the high 
energy demand and exposure to light retina are postulated to be particularly susceptible to 
oxidative stress(Kumari, Panda, Mangaraj, Mandal, & Mahapatra, 2008). In diabetic retina, 
the potential sources of reactive oxygen species (ROS) are still unclear, although a number 
of studies showed that interconnecting biochemical mechanisms endow to the pathogenesis 
of DR.  Evident studies suggest that  high glucose and the diabetic state vitalize flux via the 
glycolytic pathway, increase cytosolic NADH, increase tissue lactate to-pyruvate ratios. 
There is also an increased tricarboxylic acid cycle flux which may flood the mitochondria 
with electrons, thereby producing excess levels of ROS (Madsen-Bouterse & Kowluru, 
2008). Other sources of ROS exemplified include inflammation, the polyol pathway and 
protein kinase C (PKC) activation stimulating mitochondrial overproduction of 
ROS(Brownlee, 2005).  (Figure 1.4).  
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Apart from the mitochondrial source of ROS other sources for the generation of ROS 
include cytochrome P450, the NADPH oxidases and nitric oxide synthases (Dröge, 2002). 
In vivo studies on streptozotocin induced diabetic rat showcased an increased production of 
ROS and similarly in vitro studies on bovine retinal endothelial cells (BREC) incubated at 
25mM glucose concentration significantly increased superoxide production in comparison 
to BREC cells incubated at 5mM glucose (Y. Du, Miller, & Kern, 2003).  
Apoptosis of retinal capillary cells a consummated phenomenon is conventionally reported 
to be present in synchronization with oxidative stress. Sight-threatening unregulated 
angiogenesis and cell death are reported to be the progressive obliteration of DR (Mizutani, 
Kern, & Lorenzi, 1996). The molecular mechanism denoted for the induction of apoptosis 
Figure1.4. General features for diabetes-induced neurovascular damage in DR. (Ola, Nawaz, 
Siddiquei, Al-Amro, & Abu El-Asrar, 2012) 
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are reported to ROS-induced mitochondrial dysfunction eventually resulting in the 
activation of caspae-3 resulting in DNA fragmentation (Anuradha, Kanno, & Hirano, 2001; 
Phaneuf & Leeuwenburgh, 2002); diabetes induced proapoptotic NFkB activation (X. Du 
et al., 1999; Romeo et al., 2002). Exposure of  rat retinal endothelial cells in an in vitro 
analysis at a glucose concentration of 25mM glucose medium endorsed a 50% increase in 
caspase-3 activity and hyperglycemia induced apoptosis, in comparison to cells exposed to 
5mM glucose medium (Kowluru et al., 2004; Kowluru, Tang, & Kern, 2001). In vivo 
studies on alloxan diabetic rats for the duration of 2-14 months to have showed similar 
results with a significant elevation in apoptosis in comparison to control group(Kowluru & 
Koppolu, 2002).  Du et al. reported in their study that long term exposure of human 
umbilical vascular endothelial cells(HUVEC) to 72 hours of high glucose concentration 
resulted in an increased generation of  ROS, NFkB activation, Nitric oxide synthase 
dependent peroxynitrite formation and induction of apoptosis(X. Du et al., 1999). 
Independent studies have demonstrated a reduction in the hyperglycemia induced apoptosis 
upon treatment of endothelial cells with antioxidants and molecular inhibitors (Anuradha et 
al., 2001; Romeo et al., 2002).                         
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CHAPTER 2 
MATERIAL AND METHODS 
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2.1 Materials 
Cryopreserved Human retinal microvascular endothelial cells (HREC) (ACBRI 181) 
purchased from Cell System; Complete Classic Medium Kit With Serum and Culture 
Boost (certificate No: 4Z0-500);   Complete Serum-Free Medium Kit With 
Recombinant RocketFuel (Certificate No: SF-4Z0-500-R); (Certificate No: 4Z0-210) 
Attachment Factor (Certificate No: 4Z0-210); antibiotic: Bac-Off® (Certificate NO: 
4Z0-643); Passage Reagent Group ( Certificate No: 4Z0-800); PRG-2 Trypsin-
EDTA Solution (Certificate NO: 4Z0-310);   all were purchased from Cell System 
(Cell Systems, 12815 NE 124th Street, Suite A Kirkland, WA 98034) 
Phosphate Buffered Saline (PBS) pH 7.4 (1X), was purchased from Gibco (Life 
Technologies, UK). TRIzol Reagent Ambion RNA [REF #15596026] was purchased 
from Life Technologies USA. Chloroform HPLC grade, Code: C/4966/15, was 
purchased from Fisher Scientific. RNase free water was from PreAnalytiX/ Qiagen, # 
1057099 Hilden, Germany. Agilent RNA 6000 Pico Kit was from Agilent 
Technologies, Waldbronn- Germany. High Capacity RNA-to-cDNA kit was 
purchased from Applied Biosystems P/N 4387406. TaqMan Gene Expression Master 
Mix (P/N 4369016). 
Tali™ image-based Cytometer from Invitrogen by Life Technologies (Catalog # 
T10796); CellROX® Oxidative Stress Reagents ( Catalog # C10443); Tali™ Apoptosis 
Kit- Annexin V Alexa Fluor 488 & Propidium Iodide (Cat # A10788); Tali™ Cell 
Cycle Kit (Cat # A10798) ; Carboxy-H2DCFDA , REF C400 (Cat # 1550062) were 
all purchased from Invitrogen by Life Technologies, USA. 
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BD Accuri™ C6 Flow Cytometer; Mouse Anti-HumanCD62E ( Cat # 551145); PE 
Mouse Anti-Human CD54 (Cat # 555511) were all purchased from  BD BioSciences, 
USA.  
Pierce® RIPA Buffer  (Cat# PF 201994); Pierce® BCA Protein Assay Kit (Cat# 
23227) were all purchased from Thermo Scientific, USA. 
Rb pAb Anti_IRS-1 (REF # AH01222),  PI3K Total antibody ( REF# 710400) wer 
purchased from Invitrogen. Rb Recombinant Oligoclonal Ab ladder- Broad range 
Marker ( Sc-2361, Lot # G1013) from Santa Cruz Biotechnology. NuPAGE® Bis-Tris 
Mini Gela (Prod # IM- 8042) NOVEX® by Life Technologies, USA.  
 
Ethical and Biosafety Approvals 
Qatar University institutional review board has exempted this study, exemption 
number: QUST-CAS-SPR-13/14-20; see Appendix. Qatar university institutional 
Bio-safety committee has approved this study, approval number: QUST-CAS-SPR-
13/14-20, see Appendix. 
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2.2 Methods 
 2.2.1 Human Retinal Microvascular Endothelial Cell culture 
 Cryopreserved HRMECs were rapidly thawed in a 37 ̊ C water bath. Thereupon  
grown and passaged in tissue culture flasks wetted with attachment factor in CSC cell 
culture medium (CSC complete medium) with modified and optimized Dulbecco’s 
Modified Eagle medium: nutrient mixture F-12(DMEM/F12) containing 10% fetal 
bovine serum (FBS), human recombinant growth factors (cultureBoost-R) a 
maintenance formulation to bring about quiescence to the cell culture for 
experimentation, 5mM normal human blood glucose concentration and Bac-off tonic 
(1:500 v/v dilution) containing synthetic fluoroquinone Ciprofloxacin  for antibiotic 
treatment.  No additional antibiotic was added to the medium. HRMECs were 
incubated at 37 ̊ C with 5% CO2 and used between passages 4 and 6 to minimize 
variability. Prior to experimentation HRMECs were seeded on the appropriate dish 
based on the assay either 100 mm, 6 well plates and 96 well plates. The culture media 
was changed at 24 hours followed by every 48 hours thereafter. Upon 80-90% 
confluency, HRMECs were serum starved for 6 hours by removing the growth 
medium and replacing it with CSC serum–free medium containing 0% FBS, 
containing 20% v/v human recombinant growth factors (Recombinant Rocket Fuel). 
Following starvation, prior to use the cells were maintained in CSC completed 
medium containing 5 or 25mM D-glucose to represent normal glucose control (NG, 
5mM) and high glucose levels (HG, 30mM) for 24 hours. As per necessity osmotic 
control were used ( Mannitol, 25mM). All the experiments were performed with 2 
biological and total of 6 technical replicates.  
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Prior to subculture/culture manual cell count was performed routinely. Harvested cell 
resuspended in culture media were mixed in equal volume of staining dye Trypan 
Blue. 25μl cell suspension resuspended in 25μl of Trypan Blue were loaded on to 
hemocytometer (Bright Line) and counted under microscope. The numbers of cells 
counted in the middle 25 squares were used in the below formula to retrieve the total 
no of cells: 
்௢௧௔௟	௡௢.௢௙	஼௘௟௟௦	௖௢௨௡௧௘ௗ
ସሺ௡௢.௢௙	௦௤௨௥௘௦ሻ   ൈ 2ሺܦ݈݅ݑݐ݅݋݊	ܨܽܿݐ݋ݎሻ ൈ 10,000 
Example: 1166/4 x 2x 10,000 = 5.8 x106 cells/ml 
2.2.2 HRMECs Treatments 
Prior to use for experimental analysis the culture plates were amassed into the 
following groups A and B with further subgrouping in A,A1, and B,B1. The group 
A1 and B1 were further sub grouped and incubated with 100nM insulin (Actrapid) for 
varying time points of 10 minutes, 1 hour, 2 hours and 4 hours. 
Group A consisted of NG/control (5mM glucose), A1 (5mM glucose + 100nM 
Insulin for 10 minutes), A2 (5mM glucose + 100nM Insulin for 1 hours), A3 (5mM 
glucose + 100nM Insulin for 2 hours) and A4 (5mM glucose + 100nM Insulin for 4 
hours). Group B consisted of HG/hyperglycemia (30mM glucose), B1 (30mM 
glucose + 100nM Insulin for 10 minutes), B2 (30mM glucose + 100nM Insulin for 1 
hour), B3 (30mM glucose + 100nM Insulin for 2 hours) and B4 (30mM glucose + 
100nM Insulin for 4 hours) .  Figure 2.1 demonstrates the work plan for insulin 
treatment. 
Actrapid is a fast or short-acting insulin with action onset within half hour and 
maximum effect approaching within 1.5-3.5 hours. The complete duration of action 
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for Actrapid insulin is approximately 7-8 hours. Based on the effectivity of the 
Actrapid insulin, various time points were chosen to analyze various types of 
parameters. Depending on the parameter to be analyzed the treated cell were 
harvested at the end of the treatment time points.  
 
 
2.2.3 Cell Growth Parameters  
2.2.3(A) Cell Viability 
The morphological cell size and count for each biological replicate was assessed prior 
to experimental procedures using Tali® Image-Based Cytometer. 25 μl of harvested 
cells washed, resuspended in 1X PBS were loaded into Tali Cellular Analysis slides. 
The average cell size and total cell concentrations for each sample were recorded. 
The proportions of live and dead cells were assessed using Tali Dead Cell Red 
reagent, a ready-to-use solution containing propidium iodide (PI). PI is a fluorogenic 
DNA-binding dye used to identify necrotic cells. PI though impermeant to live cells, 
Figure 2.1. Insulin Treatment work plan (Prepared using Microsoft Word document) 
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gives  red fluorescence upon binding to nucleic acids of the dead cell giving an 
enhanced fluorescence of 20 to 30 folds.  
The treated cells were harvested by trypsinization using 3ml of 0.25% (v/v) Trypsin 
EDTA (TE), incubation at 37 ̊ C for 5-7 minutes followed by centrifugation at 500x g 
and washing with PBS (phosphate Buffered Saline) prior to staining. 1 μl of Tali 
Dead Cell Red reagent was added to 100 μl sample cell suspension in microcentrifuge 
tube. The mixture was vortexed  briefly and incubated in dark at room temperature 
for 1-5 minutes. 25 μl of the stained cells were loaded into Tali Cellular Analysis 
slide and cell viability of all samples were analyzed using Tali® Image-Based 
Cytometer at 535/617 nm excitation/emission (Ex/Em) wavelength. 
 
2.2.3(B) Apoptosis 
Apoptosis a carefully regulated  cell death proceeding of normal cell development, if 
unregulated implicate disease state. The percentage apoptotic cells at discrete 
treatments were assessed using Tali Apoptosis Kit- Annexin V Alexa Fluor® 488 and 
Propidium Iodide. Annexin V has high affinity for phosphatidyl serine (PS), a 
characteristic of apoptotic cells where PS is translocated  and exposed to the external 
cellular environment. PI as explained above binds to nucleic acids of dead cells. 
Trypsinization using 3ml TE harvested the treated, incubation at 37 ̊ C for 5-7 
minutes followed by centrifugation at 500x g and supernatant was discarded.  The 
cells were resuspended in 100 μl of 1X Annexin binding buffer (ABB) and 5 μl of 
Annexin V Alexa Fluor® 488 in a microcentrifuge tube. The mixture was vortexed  
briefly and incubated in dark at room temperature for 20 minutes. This was followed 
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by centrifugation at 500x g and resuspension in 100 μL of ABB and 1 μL  of Tali® 
PI, brief mixing and incubation in dark at room temperature for 1-5 minutes. 25 μl of 
the stained cells were loaded into Tali® Cellular Analysis slide and percentage 
apoptosis of all samples were analyzed using Tali® Image-Based Cytometer at 
488/499 nm and 535/617 nm Ex/Em wavelength for Annexin V Alexa Fluor® 488 
and PI respectively.    
 
2.2.3(C) Oxidative Stress 
Cell-ROX® Oxidative Stress Reagents, fluorogenic probes were used to reliably 
measure ROS in live cells of all the various treatments. In the normally reduced cell 
states the cell-permeable reagents are reported to be non-fluorescent or weekly 
fluorescent while, exhibit strong fluorogenic signals at oxidation states. 
Treated cells harvested using 3ml TE were centrifuged and resuspended in 200 μl 
PBS. 5μM (0.4 μl ) Cell-ROX® orange reagent was added and the mixture was 
briefly vortexed followed by incubation at 37 ̊C for 30 minutes. This was superseded 
by centrifugation at 500x g, medium removal and cell wash three times with PBS. 25 
μl of the stained cells were loaded into Tali Cellular Analysis slide and cell viability 
of all samples were analyzed using Tali® Image-Based Cytometer at 545/565 nm 
Ex/Em wavelength. 
2.2.3(D) Cell Cycle Analysis 
The amount of  DNA in cells are precise reflection of the cell cycle phase therefore, 
cellular DNA content quantification for monitoring cell cycle progression of the 
treated HRMECs were performed using Tali® Cell Cycle Kit. Treated cells 
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trypsinized in 3ml TE, incubated at 37 ̊C for 5-7 minutes were harvested and 
resuspended in 200 μl PBS. This followed centrifugation at 500x g for 5minutes. The 
supernatant was removed and pellet resuspended in 200 μl PBS followed by second 
centrifugation for 5 minutes and transfer of tubes to ice.  The PBS supernatant was 
discarded and cell pellet fixed slowly with 70% ice cold ethanol. The fixed samples 
were stored at -20 ̊ C overnight prior to staining and analysis. Before staining the cells 
were centrifuged at 1000x g for 5minutes at 4̊ C, resuspended in 1ml PBS and 
recentrifuged at 500x g for 10 minutes at 4̊ C. The washed cell pellet were incubated 
in 200 μl of Tali® Cell Cycle solution (all-in-one solution: PI, RNase A, and Triton® 
X-100) for 30 minutes in dark. Henceforth, the cells were briefly vortexed and 25 μl 
of the stained cells were loaded into Tali Cellular Analysis slide and cell viability of 
all samples were analyzed using Tali® Image-Based Cytometer at 535/617 nm 
Ex/Em wavelength. 
 
2.2.4 Immunocytochemistry/ Fluorescent Microscopy 
2.2.4(A) Reactive Oxygen Species (ROS) 
6-carboxy-2’,7’-dichlorodihydrofluorescein diacetate (Carboxy-H2DCFDA), a 
chemically reduced acetylated form of fluorescein was used as an indicator of ROS in 
live cells using fluorescent microscope. It is non-fluorescent molecules that upon 
reaction with intracellular esterase and oxidation by ROS readily are converted into 
green-fluorescent (BRANDT & KESTON, 1965). 
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Cells seeded in 6 well plates after treatments as mentioned in the above sections 
2.2.1(A) and 2.2.1(B) were washed with PBS after the aspiration of culture media. 
The cells were incubated in 2ml prewarmed PBS and 10μM (2μl) Carboxy-
H2DCFDA dye for 5-60 minutes at 37 ̊ C. The buffer was then replaced with 
prewarmed growth medium and multiple fluorescent images were captured using 
Immunofluorescent inverted microscope(Olympus X53) at ̴ 492-495/517-527 nm 
Ex/Em wavelength.      
2.2.4(B) Reactive Nitrogen Species (RNS) 
Intracellular NO was analyzed with DAF-FM diacetate, a cell-permeant 
nonfluorescent compound that  passively diffuses across the cellular membrane and 
react with intracellular NO forming fluorescent benzotriazole (Kojima et al., 1998).  
HRMECs seeded on 6 well plates after treatment as mentioned in the above sections 
2.2.1(A) and 2.2.1(B). Adherent cells were incubated with 10μM (4μl) DAF-FM 
diacetate in 2 ml of culture media for 20-60 minutes at 4-37 ̊ C. Excess probes on 
cells were washed with PBS thereafter and incubated for additional 15-30 minutes in 
2ml PBS to allow complete de-esterification of intracellular diacetates.  At the 
fluorescence Ex/Em maxima of 495/515 nm the adherent cells were imaged for 
intracellular RNS concentration using Immunofluorescent inverted microscope 
(Olympus X53).  
2.2.4(C) Fluorometric Nitric Oxide Assay 
NO production was assessed using Abcam’s Nitric Oxide Assay Kit (Fluorometric 
Cat # ab65327) indirectly by evaluating the level of its oxidized forms (nitrites and 
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nitrates) in all HRMECs seeded on 6 well plates after treatment as mentioned in the 
above sections 2.2.1(A) and 2.2.1(B). A standard curve was accomplished for the 
measurement levels between 0 and 1000 pmol/well standard. The cell lysate for all 
the treated samples were generated using the kit provided assay buffer. 75 μl of 
standards and samples in 96 well plates were exposed to 5 μl of enzyme cofactor and 
5 μl of nitrate reductase with incubation at room temperature for 4 hours. Henceforth, 
5 μl enhancer was added with 30 minutes incubation to quench interfering 
compounds. 5 μl of fluorescent DAN probe (2, 3 diaminonaphthalene) with 10 
minutes incubation followed the addition of 5 μl NaOH with 10 minutes at room 
temperature incubation to enhance the fluorescent yield. The plates were read in 
fluorometer using Ex/Em= 360/450.    
      2.2.5 Cell Migration Assay 
The effect of insulin on normal and high glucose induced migration of HRMEC was 
evaluated by scratch wound assay. In brief, upon 80-90% confluency of HRMECs in 
6-well plates, the cells were starved with serum-free medium for 6 hours followed by 
24 hours glucose treatment as described in sections 2.2.1(A) and 2.2.1(B). When the 
HRMECs had grown to confluence, a wound was made of appropriate width using 
1000 μl pipette tip. Then, the HRMECs were washed with sterile 1xPBS to remove 
the floating cell. This was followed by incubation with complete medium containing 
5mM and 30mM glucose concentrations and with or without 100nM insulin. The 6-
well culture plates were incubated at 37 °C in a 5% CO2 incubator.  The migration of 
cell monolayer was photographed (Olympus X53) at 0 hour, 2hrs, 4hrs and10hrs. 
Three fields were photographed for each well. The migration distance was measured 
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by using Microsoft Office Picture Manager. The experiment was performed with two 
biological replicates with similar results.  
2.2.7 Gene Expression Analysis 
2.2.7(A) RNA Extraction 
Total RNA was extracted using an establish technique in the lab. 
Briefly, treated cells as described in sections 2.2.1(A) and 2.2.1(B) were harvested 
with insulin treatment for 10mins and 1hrs in TRIZOL® reagent. 0.2 ml of 
chloroform was added to microcentrifuge tubes containing TRIZOL® homogenized 
samples shook vigorously. The time of 10min and 1hrs gene expression analysis 
where chosen since the gene expression/ transcription completes within 1 hour time 
span. The samples were centrifuged at 12,000 x g for 15 minutes at 4 ̊ C and the 
aqueous layer was carefully recovered in fresh tubes. 0.5 ml of chilled 100% 
isopropanol was added to the aqueous layer. After incubation period of 10 minutes, 
the samples were centrifuged at 12,000 x g for 15 minutes. The pellet was washed 
with 1000 μl of 75% ethanol; air dried, resuspended in RNase-free water and 
quantified spectrophotometrically using Nano Drop. (A260/A280) and its quality was 
checked by the Agilent Bioanalyzer. 
2.2.7(B) cDNA Preparation 
To generate cDNA, 1000ng of total RNA was utilized with High Capacity RNA-to-
cDNA Kit. The reaction mixture consisted of the following components per reaction 
for a total reaction volume of 20 μl: 10 μl 2X RT Buffer, 1.0 μl 20X Enzyme Mix, up 
to 9 μl RNA samples and quantity sufficient to 20 μl Nuclease-free water. Reverse 
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transcription reaction was performed in Thermo cycler (Gene Amp®, PCR System 
9700). 
2.2.7(C) Quantitative Real Time PCR 
Quantitative Real time RT-PCR was performed using Applied Biosystem® 7500 Real 
Time PCR system and  TaqMan® Gene Expression Master Mix (Applied Biosystem). 
The reaction mixture (total volume 10μl) consisted of the components as indicated in 
Table2.1.   All the samples were quantified for IRS1, IRS2, eNOS, PI3K, Akt, NFkB 
and VEGFA. The primers are shown in Table2.2. Normalization was performed to 
Ubiquitin (UBC) to elucidate for differences in reverse transcription efficiencies of 
cDNA.  
Table 2.1: RT-PCR Reaction Mixture 
RT-PCR Reaction Mixture for IRS1, IRS2, eNOS, 
PI3K, Akt and NFkB 
Components Component 
Volume/Reaction (μl) 
20X PP (Primer) 0.5 μl 
2X Master Mix 5 μl 
cDNA 4 μl 
Nuclease-free 
Water 
0.5 μl 
RT-PCR Reaction Mixture for VEGFA 
10X PP (Primer) 1 μl 
2X Master Mix 5 μl 
cDNA 4 μl 
Nuclease-free 
Water 
0 μl 
RT-PCR Reaction Mixture for UBC 
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40X PP (Primer) 0.25 μl 
2X Master Mix 5 μl 
cDNA 4 μl 
Nuclease-free 
Water 
0.75 μl 
  
 Table 2.2: Oligonucleotide sequences RT-PCR 
Genes   Primer Sequences ( 5’ 3’) 
UBC (Human) IDT (Hs.PT.39a.22214853) 
IRS1 (Human) Life Technologies (Hs00178563_m1) 
IRS2 (Human) Life Technologies (Hs00275843_s1) 
eNOS (Human) Life Technologies (Hs01574659_m1) 
PI3K (Human) IDT (Hs.PT.58.96974) 
Akt (Human) IDT (Hs.PT.58.26215470) 
VEGFA (Human) IDT (Hs.PT.56a.1149801.g) 
NFkB (Human) IDT (Hs.PT.58.21008943) 
 
2.2.8 Protein Adhesion Assay by Flow Cytometer 
Cell surface expression of adhesion molecules P-Selectin and ICAM1 on the control 
and treated cells were detected using BD Accuri TM C6 Flow Cytometer (BD 
Biosciences). Cell-suspensions of pooled two biological replicates of the treated 
samples mentioned in the above sections 2.2.1(A) and 2.2.1(B) were stained with PE 
Mouse Anti-Human CD62E ( P-Selectin) and PE Mouse Anti-Human CD54 (ICAM-
1). 500 μl cell suspensions of all samples in 1XPBS were incubated in dark with 20 μl 
of the CD62E and CD54 antibodies respectively for 20 minutes. The cells were 
washed twice in 1XPBS prior to analysis by BD Accuri TM C6 Flow Cytometer. 
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Unstained control cell suspensions in 1XPBS were used to create the gating based on 
the cell size and granularity by forward and side scatter. Analysis of 20,000 events 
was performed on BD Accuri TM C6 Flow Cytometer using BD Accuri TM C6 
Analysis software. 
2.2.9 VEGFA antibody analysis by ELISA 
VEGFA antibody was detected in the condition medias of all samples using 
BioVendor Human VEGFA ELISA kit (Cat. No: RAF136R). 
50 μL of the 1:2 dilute sample condition media and standard was added to the 
antibody coated micro-wells followed by incubation for 2 hours on a microplate 
shaker. Following the incubation unbound biological compounds were removed by 
washing followed by incubation with 100μL biotin conjugate for 1hr on microplate 
shaker. Unbound biotin-conjugated anti-Human VEGFA antibody was removed by 
washing. The samples were incubated with 100μL Streptavidin-HRP on the shaker 
for 1hrs to bin to the biotin-conjugated anti-Human VEGFA antibody. Following the 
washing step 100μL of TMB-substrate solution was added with incubation for 10 
minutes leading to the formation of colored complex . 100μL of stop solution was 
added to terminate the reaction followed by absorbance reading at 620nm in 
TECAN® ELISA reader. The concentrations of the samples were calculated by 
plotting the absorbance Vs standard concentration curve.   
2.2.10  Western Blotting 
2.2.10(A) Protein Extraction 
Confluent  treated cultures as mentioned in the above sections 2.2.1(A) and 2.2.1(B) 
were washed twice with cold PBS to remove any traces of media. The cells were 
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homogenized using Thermo ScientificTM RIPA lysis and Extraction buffer, kept on 
ice for 5 minutes and collected using cell scraper. The collected lysate were 
centrifuged in a microcentrifuge tube at 14,000 rpm for 15 minutes at 4 ̊ C. The 
supernatant was separated and stored in -80 ̊ C until used for further analysis. 
2.2.10(B) Protein Analysis 
Protein analysis was performed using PierceTM BCA Protein Assay Kit. Nine 
different BSA protein standards from 0-2000μg/mL were prepared. To perform the 
assay, 25µl of each BSA standards and test samples were pipetted in duplicate into a 
96-well flat bottom ELISA plate followed by addition of 200µl of BCA working  
reagent. The samples were allowed to mix on a shaker followed by incubation at 37 ̊ 
C for 30 minutes. The samples were read spectrophotometrically at 562nm using 
TECAN SunriseTM microplate reader. A 1:2 0r 1:3 dilution of samples were prepared 
if the samples were highly concentrated. 
2.2.10(C) SDS-PAGE/Electrophoresis 
SDS-PAGE was performed using ready to use NuPAGE® Bis-Tris Mini Gels. The  
gel plates after the removal of the gel cast comb were gently placed in to rigs and 
filled with 1X running buffer initially to check for leakage. The gaps between glass 
plates in the gel rig were then filled with 1X running buffer to immerse the gels 
completely in buffer. 40 μg of protein samples were at 95 ̊ C for 5 minutes in 7.9 μl of 
loading buffer with 2% β-Merceptoethanol (βME), cooled on ice for 2 minutes 
followed by centrifugation at 5000 rpm for 1 minute. Equal amounts of proteins per 
sample were loaded each well of  NuPAGE® Bis-Tris Mini Gels following the 
addition of molecular weight marker in the first well. The electrophoresis was run at 
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200 volts for 40-45 minutes. Upon the reaching of the dye from the loading buffer to 
the bottom of the gel, electrophoresis was terminated and plates removed. The 
stacking gel was cut and gel was removed from the cassette.  
2.2.10(D) Western Blotting Protocol 
The Bio-Rad semi-dry electroblot apparatus was prepared by placing 2 sheets of 
blotting pads, cut to the size of the gel and soaked in transfer buffer, on a ceramic 
transfer platform. One sheet of filter paper of exact the gel size soaked  in transfer 
buffer was added next followed by the resolving gel. Next one sheet of nitrocellulose 
membrane exact size of the gel wetted in methanol was placed followed by one filter 
paper and two further sheets of blotting pads (all soaked in transfer buffer) (Figure 
2.2). The lid was placed and was tightly secured close and the blot module was filled 
with transfer buffer until the gel/membrane sandwich gets covered in transfer buffer. 
The electroblot was run at a current of 30 volts for 1 hour. 
 
 
 
 
 
 
 
 
After transfer, the membrane was briefly rinsed in distilled water and the transfer 
efficiency was evaluated using Ponceau S Solution (Sigma Aldrich). The membrane 
Figure 2.2: Western Blot Transfer Technique ("Life 
Technologies," 2015) 
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was rinsed again for 5-10 minutes to wash off Ponceau S dye. Blocking solution 
containing 5% (w/v) non-fat milk in 1X TBST ( Tris Buffered Saline with Tween® 
20) was used to incubate the membrane for one hour. After, incubation, it was 
incubated 1% (w/v) non-fat milk blocking solution containing 1:1000 dilution of the 
primary antibodies for the proteins of interest (Rabbit polyclonal Anti-IRS-1,Human 
PI3K Recombinant Rabbit Oligoclonal Antibody and Human Anti-Actin antibody) . 
The incubation was performed for overnight at 4 ̊ C on the shaker. 
Succeeding  incubation, antibody containing blocking solution was removed and 
stored at 4 ̊ C for future use. The membrane was rinsed 3 times with 1X TBST for 5-
10 minutes and was reincubated in blocking solution containing  1:1000 dilution of 
secondary antibody for 3 hours at room temperature on a shaker. The secondary 
antibody used was species specific IgG conjugated anti-rabbit antibody. Post 
incubation, diluted antibody was removed and stored at 4 ̊ C for reuse.  The 
membrane was rinsed 3 times in 1x TBST for 5-10 minutes.  Immune complexes 
were detected using Western Blot Chemiluminescent Substrate ECL reagent 
containing substrates for horseradish peroxidase (HRP) or other probes. The 
membrane was incubated for 5 minutes in a HRP working solution consisting of 
equal volumes of stable peroxide solution (ECL A) and an enhanced luminal solution 
(ECL B).  The chemical reaction with the antibodies and chemiluminescent substrate 
emits light at 425 nm captured with digital imaging device. Ten subsequent images 
were collected for each blot.  
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2.2.11 Statistical Analysis 
Data were checked for normal distribution and are presented as mean (SD) for 
continues variables unless mentioned otherwise. Each experiment was independently 
repeated at least 3-5 times. All values in the figures are expressed as mean with 
standard deviation.  
To determine statistical significance, the values were compared versus control and 
HG (as a control or reference day) with paired Student’s t -tests. Statistical 
significance of difference between groups was tested using Student's t-test or if there 
were more than two groups, using one way analysis of variance (ANOVA) followed 
by posthoc analysis. A P value of  .05 or less was considered to be significant. All 
calculations were performed using Graphpad prism 6 for windows. 
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CHAPTER 3 
RESULTS 
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3. RESULTS 
3.1  HRMECs Morphology and cell count 
To study the effect of experimental  hyperglycemia on insulin-stimulated HRMECs, 
the cells were carefully monitored for growth, morphology, vitality and their  
response to different treatments.  
Cryopreserved HRMECs were resurrected and proliferated. The following Figure 3.1 
was captured by an inverted microscope at 10x lens (Image A-E) which shows the 
procedural growth and proliferation in 100mm culture plates:  
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D
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Figure 3.1. HRMECs growth pattern. A, Day 0: seeded cells non-adherent to the culture 
plate. B, Day 2: cells adherent to the culture plate with 10% confluency. C, Day 4: 80-
90% confluent cells necessary prior to different glucose treatments. D, Day 5: 6 hours 
Serum Free media treatment followed by 5 & 30mM glucose treatment. E, Day 6: 24 
hours after glucose treatments followed by 100nM insulin treatment. 
3.2 Cell Growth Parameters 
3.2.1  Cell Viability 
The viability of the cell is an important parameter performed to assess the viability, 
uniformity and standardization of all type of cell samples used in the experimental 
procedure. These are imperative in verifying the health of the cells in culture as well as 
the extent of toxicity of the treatments during experimental propagation. The 
morphological assessment was performed by Tali® Image-Based Flow Cytometer 
revealed that on an average the total concentration of cells or cell count of all the 
10X
E
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biological and technical replicates ranged from 3 x106 cells/ml to 5x106 cell/ml. The 
average cell sizes measured by cytometer were 12-14μm (micrometers). 
 The cell viability test as performed by evaluating the percentage of live and dead cells 
revealed that insulin treatment for HG cells increased the cell survival with a significant 
(p ˂ 0.05) increase in the percentage of live cell after 10 minutes, 1hour, 2hours and 
4hours by 1.13, 1.1 ,1.13 & 1.13 folds ( % of live cell after insulin treatment= 94±1.5, 
93±1.5, 94±1.5 and 94±1.5) respectively as shown in the figure8. Equivalently, a 
corresponding 2.6,2.4, 2.6 &2.8 fold decrease (6.5± 1.5, 7± 1.5, 6.5± 1.5 & 6.5± 1.5) 
respectively in the number of dead cells were seen in treated cells as shown in figure 3.2. 
However, in comparison to the NG cell 24 hour HG cells, showed  a significant reduction 
in live cells (92.5± 0.5 Vs 83± 0.5) with p ˂ 0.05, as shown in figure 3.2 and an elevation 
in the percentage of dead cells (7.5 ± 0.5 Vs 17 ± 2). (Figure 3.2 A & B) 
A. Live Cells 
 
 
 
 
 
 
 
 
 
 
Figure 3.2 (A): Effect of insulin treatment on cell viability (live Cells). The percentage of live cells. 
Data are presented as means ±SD of 2-3 independent experiments analyzed by ANOVA with post-hoc 
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test for multiple experiments. * p ˂ 0.05 compared within the HG group #p ˂ 0.05  compared with NG, 
t-test.  
B. Dead Cells 
 
Figure 3.2 (B). Effect of insulin treatment on cell viability (Dead Cells). The percentage of Dead.  Data 
are presented as means ±SD of 2-3 independent experiments analyzed by ANOVA with post-hoc test 
for multiple experiments. * p ˂ 0.05 compared within the HG group #p ˂ 0.05  compared with NG, t-
test.  
3.2.2 Cell cycle Analysis 
Cell cycle analysis performed by Tali® Cell Cycle Kit revealed that neither high glucose 
nor insulin treatment affect the growth pattern of the cells or growth arrest. No significant 
difference was detected between NG cells, HG cells and after its treatment with insulin at 
different time points (p >0.05) as shown in figure 3.2 (C).  
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Figure 3.2(C), Cell cycle phases in HRECs under different conditions; NG (5mM glucose), HG (30mM 
glucose) and after insulin treatment to HG cells at 10 min, 1, 2, and 4 hours. Data are presented as Means 
±SD of 2-3 independent experiments analyzed by ANOVA with post-hoc test for multiple experiments. 
Two-tailed p value is significant at p ≤ 0.05. 
3.3   Effect of high glucose  and insulin on apoptosis and oxidative stress  
To investigate whether insulin treatment to hyperglycemic cell induces a positive or 
negative impact on the rate of apoptosis HRECs were assessed for apoptosis using Tali 
Apoptosis Kit- Annexin V Alexa Fluor® 488 and Propidium Iodide. High glucose 
(30mM) significantly increased the number of the apoptosis in HRMECs  by 3.8 folds, 
2.25±0.48 Vs 8.75 ±1.109 (p value 0.0017). Contrary to this 100nM insulin treatment to 
HG cells causes a significant reduction in the number of the apoptotic cells in comparison 
to untreated HG cells after 10mins, 1hr, 2hrs & 4hrs of the insulin treatment by 
C. 
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1.7,1.5,1.6 & 2.3 folds with the corresponding *p values were 0.0094, 0.0275, 0.0161 and 
0.0004, respectively as shown in figure 3.3. 
 A.                                                                            B. 
 
 Figure 3.3. Effect of high glucose and 100nM insulin on apoptosis. Fig A, Annexin V and PI stained 
HRMECs shown by Tali® Image based cytometer whereas red spots indicates the numbers of deal cells , 
and green spots for apoptotic cells. B, Bars shows the data presented as Means ±SD of 2-3 independent 
experiments analyzed by ANOVA with post-hoc test for multiple experiments. Two-tailed p value is 
significant at p ≤ 0.05. * p ˂ 0.05 versus the untreated HG group, and  #p ˂ 0.05  compared with NG 
group.. 
Two independent techniques; Tali® CellROX® Oxidative Stress Reagents (quantitative 
assessment) and immunofluorescence (qualitative assessment) were used to examine the 
oxidative stress in HRMECs exposed to 5mM and 30mM glucose for 24 hours in 
comparison to HG cells treated with 100nM insulin. CellROX® Oxidative Stress analysis 
revealed a significant increase in the oxidative stress to cells exposed to high glucose in 
comparison to the cells under normoglycemic conditions (control group) by 2 folds( 
70.17 ± 5.160 Vs 35.67 ± 6.420) (#p ˂ 0.05). Contrary to this finding 100nM insulin 
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treatment for 10 min, 1hrs, 2hrs & 4hrs resulted in a significant  reduction in oxidative 
stress. The corresponding p values are 0.0393, and ˂ 0.0001 for 10min and 
1hrs,2hrs,4hrs, respectively as shown in (Figure 3.4 A, B). 
Similar to the Tali® CellROX® results, a qualitative assay by the immunofluorescence 
utilizing H2DCFDA dye exhibited a strong fluorescence in HRMECs exposed to high 
glucose compared to control cells. Evident weak signals were recorded with reduction in 
ROS spots upon insulin treatment in both the groups (NG and HG) in time based manner 
as shown in figure 3.4 C&D. 
A.                                                              B. 
  
Figure 3.4. Effect of High glucose and 100nM insulin applications on ROS.. A, Tali® CellROX® 
Oxidative Stress Reagents stained HRMECs shown by Tali® Image based cytometer. B, Significant 
association between insulin treatment on HG cells and untreated HG cells to oxidative stress * p ˂ 0.05 
compared within the groups performed by One-way ANOVA; #p ˂ 0.05  compared with NG, t-test. 
 
60 
 
     
  
Control High Glucose
Control+1hour Insulin Glucose+1Hour Insulin
Control+2hour Insulin Glucose+2Hour Insulin 
Control+4hour Insulin Glucose+4Hour Insulin
C. D. 
1 
3
1 
2 2 
3 
4 4 
61 
 
Figure 3.4 (C and D). Immunofluorescence for ROS production signal in each group shown in panel C and 
D.C1, HRMECs cultured in 5mM glucose. C2, HRMECs cultured in 5mM glucose and treated with 100nM 
Insulin for 1hrs. C3,5mM glucose and treated with 100nM Insulin for 2hrs. C4, 5mM glucose and treated 
with 100nM Insulin for 4hrs. D1, HRMECs cultured in 30mM glucose. D2, , HRMECs cultured in 30mM 
glucose and treated with 100nM Insulin for 1hrs. D3,30mM glucose and treated with 100nM Insulin for 
2hrs. D4, 30mM glucose and treated with 100nM Insulin for 4hrs. 
3.4 Effect of high glucose and  insulin treatment on NO production 
To study the effect of experimental hyperglycemia on NO production in HRMECs, 
treated with insulin at different time points the NO production in HRMECs cultured for 
24hrs in 5 and 30mM glucose were examined by two independent parameters: Abcam’s 
Nitric Oxide Fluorometric Assay Kit and DAF-FM and DAF-FM Diacetate 
Immunofluorescence dye.  
Plot for the fluorescence vs. Pico moles nitrates were analyzed to determine the sample 
nitrite concentrations. Figure 3.5(A) illustrates the RFU (Relative Fluorescence vs Nitrite 
concentration (pmol/well/4hrs) for experimental standards to generate the relative 
concentration of the unknown samples. 
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Figure 3.5(A): RFU (Relative Fluorescence vs Nitrite concentration (pmol/well/4hrs) for  experimental 
standards to generate the relative concentration of the unknown samples 
Table 3.1. Shows the calculated mean nitrite concentration of all samples: 
Sample Nitrite Concentration in p mol 
NG (5mM glucose)  1.9  
HG (30mM glucose) 6.4 
HG+ Insulin  10mins 1.4 
HG+ Insulin  1hrs 1.0 
HG+ Insulin  2hrs 0.96 
HG+ Insulin 4hrs 1.0 
Mannitol 1.5 
NG+ Insulin  10mins 2.4 
NG+ Insulin  1hrs 1.0 
NG+ Insulin  2hrs 1.3 
NG+ Insulin  4hrs 1.4 
 
The measurement of nitrite the oxidized product of NO was assayed by the fluorometric 
method revealed a significant increase in NO  production in cells exposed to  30mM 
glucose compared to control exposed to 5mM glucose by ≈3.4 folds (1.9 ± 0.62 
pmol/well/4hrs Vs 6.4 ± 0.78 pmol/well/4hrs, t-test) (# p value ˂0.05, p value: 0.0466)  . 
However, when compared to 30mM glucose treated HRMECs, insulin- stimulated NO 
synthesis were  significantly reduced at 10min, 1hrs, 2hrs & 4hrs of insulin treatment for 
both NG and HG groups. The corresponding *p value for all samples were ˂0.0001. In 
contrast, insulin had no significant effect on NO synthesis in HRMECs cultured in 30mM 
glucose in comparison to basal 5mM glucose.  
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Figure 3.5(B). Insulin reduces glucose stimulated NO production in HG as well as NG cells. Bars shows 
the data presented as means ±SD of 2-3 independent experiments analyzed by ANOVA with Dennett’s 
post-hoc test for multiple comparisons between individual groups. Two-tailed p value is significant at p ≤ 
0.05. **** P ˂ 0.05 versus the untreated HG group, and #p ˂ 0.05 compared with NG group 
Significant association between insulin treatment on HG cells and untreated HG cells to 
NO * p ˂ 0.05 compared within the groups performed by One-way ANOVA; #p ˂ 0.05  
compared with NG, t-test. 
Immunofluorescence staining with DAF-FM diacetate immunofluorescence dye were 
performed and in confirmation showed similar findings with the above fluorometric assay 
results. Immunofluorescence results showed strong RNS signals with HG cells which 
decreases and gave week signals for RNS with insulin treated  cells as evident in the 
figure 3.5(C &D). 
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Figure3.5 (C&D). Immunofluorescence for RNS production signal in each group in two panels C: NG 
group and D: HG group. C1, HRMECs cultured in 5mM glucose. C2, HRMECs cultured in 5mM glucose 
and treated with 100nM Insulin for 1hrs. C3,5mM glucose and treated with 100nM Insulin for 2hrs. C4, 
5mM glucose and treated with 100nM Insulin for 4hrs. D1, HRMECs cultured in 30mM glucose. D2, , 
HRMECs cultured in 30mM glucose and treated with 100nM Insulin for 1hrs. D3,30mM glucose and 
treated with 100nM Insulin for 2hrs. D4, 30mM glucose and treated with 100nM Insulin for 4hrs. 
3.5 PI3K/Akt pathway, eNOS, VEGF-A, and NFKB gene expression analysis 
To investigate the inhibitory effect of insulin on NO production gene expressions of IRS-
1,IRS-2,PI3K,Akt and eNOS involved in the PI3K/Akt insulin signaling pathway were 
analyzed using specific primers as stated earlier and against UBC as housekeeping 
control gene. Prior to mRNA expression analysis, RNA purity and concentrations for 
each sample was spectrophotometrically evaluated using Nano drop. The Table 3.2 below 
show records of the RNA concentration and purity: 
Table 3.2. RNA concentration and Purity 
Sample RNA 
quantity 
(ng/μl) 
RNA purity 
(260/280) 
NC 671.4 1.80 
HG 882 1.82 
HG+INS10min 792 1.89 
HG+INS1Hrs 1095.2 1.94 
NG+INS10min 708.3 1.93 
NG+INS1Hrs 859 1.94 
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To test the effect of glucose and insulin at different time point on PI3K/Akt pathway, 
HRMECs were exposed to 5mM or 30mM glucose for 24 hours followed by 100nM 
insulin treatment for 10mins and 1hrs followed by RNA extraction and cDNA 
preparation based on RNA concentrations. 
Real Time RT-PCR expression analysis of IRS-1 mRNA in HRMECs exposed to 5 or  
30mM glucose revealed no significant change in the expression levels. However, insulin 
treatment of HG cells for 1hr produced a significant upregulation of IRS-1 mRNA gene 
expression with ≈97 fold increase p value 0.0002 as shown in  Figure 3.6(A). Similar to 
IRS-1 gene expression, IRS-2 mRNA gene expression was significantly increased by 
≈139 fold with 1hrs of insulin treatment in  HG cells [30mM glucose for 24h] with a p 
value of 0.0049. Control cell [NG] exposed to 5mM glucose for 24hrs when treated with 
10mins insulin resulted in ≈112 fold increase in IRS-2 gene expression with p value 
0.0143.  IRS-1, IRS-2 gene expressions are not significantly different between HG and 
NG groups   as shown in (Figure 3.6B). 
A.                                                                                            
 
 
 
 
Figure3.6(A): Real Time quantitative RT-PCR analysis of IRS-1 in RNA extracts of HRMECS exposed to 
5 or 30mM glucose for 24hrs followed by 100nM insulin treatment for 10mins and 1hrs. Bars shows the 
data presented as means ±SD of 2-3 independent experiments analyzed by ANOVA with Dennett’s post-
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hoc test for multiple comparisons between individual groups. Two-tailed p value is significant at p ≤ 0.05. 
**** P ˂ 0.05 versus the untreated HG group, and **p ˂ 0.05 compared with NG group 
B.  
 
 
 
 
 
 
 
Figure3.6(B): Real Time quantitative RT-PCR analysis of IRS-2 in RNA extracts of HRMECS exposed to 
5 or 30mM glucose for 24hrs followed by 100nM insulin treatment for 10mins and 1hrs. Bars shows the 
data presented as means ±SD of 2-3 independent experiments analyzed by ANOVA with Dennett’s post-
hoc test for multiple comparisons between individual groups. Two-tailed p value is significant at p ≤ 0.05. 
**** P ˂ 0.05 versus the untreated HG group, and **p ˂ 0.05 compared with NG group 
 
The mRNA expressions of PI3K, Akt and eNOS respectively showed a significant 
upregulation in expression following 24hrs HG exposure by 4.2, 1.6 and 8.7 folds, 
compared to cells exposed to 5mM glucose group with the corresponding p values are 
0.0072, 0.049 and 0.018 respectively as shown in Figure3.6(C, D &E).  
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C. 
 
Figure 3.6 (C): Real Time quantitative RT-PCR analysis of PI3K in RNA extracts of HRMECS. Two independent 
biological samples with three technical replicates analyzed. *p value ˂  0.05 for differences between control, HG and 
insulin treated HRMECs were considered significant. 
D.                                                                                              
 
 
 
 
 
 
 
Figure 3.6(D): Real Time quantitative RT-PCR analysis of Akt (D) in RNA extracts of HRMECS exposed to 5 or 
30mM glucose for 24hrs followed by 100nM insulin treatment for 10mins and 1hrs. Two independent biological 
samples with three technical replicates analyzed. *p value ˂  0.05 for differences between control, HG and insulin 
treated HRMECs were considered significant. 
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E.  
 
 
 
 
 
 
Figure 3.6(E): Real Time quantitative RT-PCR analysis of eNOS (E) in RNA extracts of HRMECS exposed to 5 or 
30mM glucose for 24hrs followed by 100nM insulin treatment for 10mins and 1hrs. Two independent biological 
samples with three technical replicates analyzed. *p value ˂  0.05 for differences between control, HG and insulin 
treated HRMECs were considered significant. 
In an attempt to investigate the differences between HRMECs culture in either glucose 
concentrations and HG treated with insulin that could be correlated to gene expression 
analysis and attenuated NO production western blot for IRS-1 and PI3K proteins was 
performed . Prior to SDS-PAGE the concentration of the protein in each sample was 
determined using TECAN® ELISA to establish the minimum viable concentration to be 
used. Plot for the absorbance vs BSA standard concentration were analyzed to determine 
the protein concentration. Figure3.7(A) . illustrates the absorbance Vs concentration for 
the experimental standard to generate the relative concentration of the unknown samples.  
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Figure3.7(A). Protein quantification  
Table3.3: Average calculated  protein concentrations of the samples. 
Sample Protein Concentration 
in ng 
50ng Protein 
Volume  (μL) 
NG (5mM glucose)  2629.5 25 
HG (30mM glucose) 2009.5 27 
HG+ Insulin  10mins 1719 25 
HG+ Insulin  1hrs 1588.167 26 
HG+ Insulin  2hrs 1498.167 27 
HG+ Insulin  4hrs 2769.5 22 
NG+ Insulin  10mins 2322 26 
NG+ Insulin  1hrs 2084.5 25 
NG+ Insulin  2hrs 2204.5 26 
NG+ Insulin  4hrs 2514.667 21 
 
Quantitative analysis of Western blots illustrated that there was no significant difference 
in expression of IRS-1(165kDa) in HRMECs cultured in either 5 or 30mM 
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glucose.(Figure3.7 B) However, a significant band was visual with 4hrs insulin treatment 
of 24hrs HG cells with ≈8 fold increase with 4hrs of insulin, p value 0.0003. PI3K 
(85kDa) did not give specific band, this could have been due to high concentration of 
protein used therefore, a plan to perform immunoprecipitation of these protein will be 
attempted.  
I.  
 
 
II. 
 
Figure3.7(B). Effects of glucose concentrations and insulin treatment on expression of IRS isoform. I &II, 
HRMEC lysate were prepared from cells cultured for 24hrs in medium containing 5mM and 30mM glucose 
and insulin treatment for 10min, 1hrs, 2hrs and 4hrs respectively. SDS-PAGE resolved lysate were 
transferred to nitrocellulose and probed with antibodies indicated. 
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3.6 Hyperglycemia stimulates VEGFA expression 
3.6.1 VEGFA  and NFkB gene expression 
To investigate angiogenesis and apoptosis in a progressive obliteration of DR, genes 
involved in angiogenesis such as VEGF-A and proapoptotic gene such as NFkB were 
assessed by Real Time RT-PCR. The relative quantitative mRNA gene expression of 
VEGF-A gene in HRMECs exposed to 30mM glucose showed a significant upregulation 
of the expression compared to the cells exposed to 5mM glucose with ≡227 fold increase 
and p value of 0.0008 as shown in   (Figure 3.8 A). The analysis of proapoptotic gene 
NFkB however, showed no difference between cells exposed to HG with cells exposed to 
normoglycemia and even treated cells with insulin under normoglycemia and 
hyperglycemic conditions (*p value ˂  0.05) as shown in  (Figure3.8B) 
A. 
 
 
 
 
 
Figure3.8 (A). Real Time quantitative RT-PCR analysis of VEGFA (F) in RNA extracts of HRMECS 
exposed to 5 or 30mM glucose for 24hrs followed by 100nM insulin treatment for 10mins and 1hrs. Two 
independent biological samples with three technical replicates analyzed. *p value ˂  0.05 for differences 
between control, HG and insulin treated HRMECs were considered significant. 
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B.  
 
Figure3.8(B). Real Time quantitative RT-PCR analysis of NFkB (B) in RNA extracts of HRMECS exposed 
to 5 or 30mM glucose for 24hrs followed by 100nM insulin treatment for 10mins and 1hrs. Two 
independent biological samples with three technical replicates analyzed. *p value ˂  0.05 for differences 
between control, HG and insulin treated HRMECs were considered significant. 
3.6.2 Effect of HG and insulin treatment on VEGF-A Protein  
Protein expression analysis of the angiogenesis protein VEGFA was performed by 
ELISA in order to correlate the findings with gene expression results.  ELISA results 
showed that the VEGFA protein expression in 24hrs HG exposed cell was significantly 
elevated by 0.16 fold than those of the NG exposed cells (p value 0.0374). In the insulin 
treated cells a significant increase in the VEGFA protein expression was recorded in 
24hrs HG exposed cells treated with 100nM insulin for only 1hrs and 4hrs by 0.26, 0.25 
fold in comparison to control cell with corresponding significant p values of ˂0.0001, 
respectively. The VEGFA protein expression in 24hrs 5mM glucose exposed cell treated 
with 100nM insulin also showed similar pattern of protein expression with significant 
elevated expression only at 1hrs and 4hrs by 0.21 and 0.23 folds with p values  were 
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˂0.0001, respectively. The figure3.9 below illustrates the VEGFA protein expression in 
HRMECs. 
 
Figure3.9. The ELISA examination of VEGF protein expression in HRMECs. The treated cells showed an 
increased VEGFA protein expression in both high glucose, insulin treated and high glucose-insulin treated 
cell. *p value ˂  0.05 for differences were considered significant. 
3.7 Insulin attenuates HRMECs barrier function 
To evaluate whether insulin had an effect on the migration of HRMECs, an in vitro 
scratch wound test was performed to measure the migration ability of HRMECs at 5mM 
and 30mM glucose with and without 100nM insulin was performed. As shown in the 
Figure 3.10, a significant wound closure was observed in the group treated 24hrs with 
30mM glucose compared to 5mM treated group. However, the HRMECs with 24hrs high 
glucose and low glucose exposer followed by co-treatment with 100nM insulin showed 
wider wound area when assessed after 4hrs, 8hrs and 12hrs. These results indicate that 
insulin could effectively significantly inhibit HG exposed HRMECs migration ability as 
shown in (Figure3.10A,B).  
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Figure3.10. Insulin inhibited HRMEC migration induced by high glucose. A, HRMECs photographed for 
re-endothelialization after wound scratch created by 1000μl pipette. B, The quantitative data of migration 
distance were from two independent experiments.  Bars shows the data presented as means ±SD of 2-3 
independent experiments analyzed by ANOVA with Dunnett’s post-hoc test for multiple experiments. 
Two-tailed p value is significant at p ≤ 0.05. * p ˂ 0.05 versus the untreated HG group, and  #p ˂ 0.05  
compared with NG group. 
3.8 Insulin down regulates adhesion molecule P-selectin in HRMECs  
To assess whether insulin had an effect on the cellular adhesion molecules P-selectin and 
ICAM-1 in HRMECs, protein expression was measured using BD® Acuri flow 
cytometer. As shown in the figure 15, the flow cytometry results revealed a significant 
increase in the P-Selectin expression in 24hrs HG exposed cell compared to NG cell with 
≈12 fold increase and p value 0.0022.  The expression pattern under the effect of insulin 
treatment in 24hrs NG followed by 100nM insulin treatment revealed a gradual 
65 
 
significant increased expression from 10mins to 1hrs and 2hrs however, no significance 
was encountered with 4hrs insulin treatment in control group treated with insulin. 
Contrary to this finding although 24hrs HG cells treated with insulin for 10mins, 1hrs and 
2hrs had significant increase by ≡20, 17 & 11 folds for P-selectin expression (p = 
˂0.0001), and there was a gradual significant decrease in the expression at 4hrs by 8.6 
fold. Consistent with this result ICAM-1 expression was significantly decreased in 24hrs 
HG exposed cells treated with insulin for 4hrs by ≈1.3 folds with p value 0.003. 
Figure3.11. 
 
 
 
  
 
 
 
 
 
 
 
 
Figure3.11.Treatment of hyperglycemic HRMECs with insulin significantly reduced expression of 
adhesion proteins  P-selectin and ICAM-1. A, Demonstrates the normal distribution of the unstained 
HRMECs for gating based on cell size and morphology, the variation in the distribution of the HRMECs 
depending on glucose exposure and insulin treatment. 
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B. 
 
Figure3.11(B).Treatment of hyperglycemic HRMECs with insulin significantly reduced expression of 
adhesion proteins  P-selectin and ICAM-1. B, Statistical analysis of the FACS results using one way 
ANOVA *p values ˂ 0.05 were considered significant.  
C. 
 
Figure3.11(C).Treatment of hyperglycemic HRMECs with insulin significantly reduced expression of 
adhesion proteins  P-selectin and ICAM-1. C, Statistical analysis of the FACS results using one way 
ANOVA *p values ˂ 0.05 were considered significant.  
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4.1. DISCUSSION 
The vascular endothelium maneuvers a crucial role in the maintenance of vascular health 
by regulating various factors such as vascular tone, platelet aggregation, coagulation and 
monocyte adhesion, amongst others. The mechanism of endothelial vascular tone 
regulation occurs through the coordinated secretion of endothelial vasodilators and 
vasoconstrictors. Abnormal vascular endothelial function, as defined by the decrease 
bioavailability of the principal vasodilator NO produced by the endothelium NOS and in 
cases of insulin resistance are well described in in vivo and in vitro studies with type 1, 
type2 diabetes and cardiovascular disorders (Salt et al., 2003; Wheatcroft, Williams, et 
al., 2003). Insulin stimulated NO productions are reported to be well established in 
cardiovascular and  macrovascular endothelium and its association with PI3K/Akt 
pathway (Montagnani et al., 2001). Contrary to this insulin signaling in retinal 
endothelium have minimal reports with some studies suggesting it to be an important 
physiology player in hyperglycemia or insulin resistance induced DR (Reiter & Gardner, 
2003).  This prompted us to investigate the association between hyperglycemia and  
insulin mediated PI3K/Akt pathway eNOS directed NO production and associated 
multivariate effect on HRMECs survival, proliferation, angiogenesis, adhesion, apoptotic 
and inflammatory markers. 
The present study demonstrates a number of important findings that contributes to the 
understanding the role of hyperglycemia and insulin-resistance in human retinal 
endothelial cell homeostasis. The key findings of the study include:  
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Hyperglycemia causes an increase in ROS/oxidative stress and apoptosis, while 
insulin promotes a significant decrease in ROS and apoptosis. These results are 
consistent with previous studies done on BRECs and mice RECs exposed to 5 and 25mM 
glucose however, these studies were performed on long term glucose exposure for 5 days 
(Madsen-Bouterse & Kowluru, 2008). The mechanism for increase ROS in 
hyperglycemic cells remain unclear however, studies suggest increased glycolytic 
pathway flux, cytosolic NADH and inflammation among other to induced mitochondrial 
ROS production (Madsen-Bouterse & Kowluru, 2008).  
In vivo studies on diabetic animals suggest a reduction in oxidative stress upon 
administration of antioxidants such as Vitamin E and aspirin among others thereby 
significantly reducing DR (Kowluru et al., 2001). Other studies reported that oxidative 
stress a leading cause of insulin resistance (Bloch-Damti & Bashan, 2005). However, all 
these studies do not report the effect of insulin for the reduction of ROS. The current 
study reports that short acting insulin treatment of 24hrs HG exposed HRMECs 
significantly reduced ROS production consistent with previous studies (Bloch-Damti & 
Bashan, 2005; Kowluru et al., 2001).  
eNOS mediated NO production increases with hyperglycemia but remarkably 
decreases with insulin treatment after 1hour, 2 hours and 4 hours. The productions 
of NO in response to high glucose concentration are quite contradicting among multiple 
studies. Cosentino et al. (1998) reported a significant elevation of NO production in 
HAECs exposed to high glucose for 5 days, contrary to this under similar conditions salt 
et la. (2003) reported a reduction in NO. Similar results are also reported in bovine retinal 
endothelial cells exposed to 25mM glucose for 5 days (Chakravarthy et al., 1998; 
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Cosentino, Hishikawa, Katusic, & Lüscher, 1997; Salt et al., 2003). Human aortic 
endothelial cells under similar conditions had elevated NO production (Cosentino et al., 
1997). The current study reports a significant increase in NO production in HRMECs 
exposed to 24hrs 30mM glucose. The dissimilarity with the above mentioned bovine 
retinal endothelial cells study could be due to different endothelial cell types used or 
varied duration of experimental hyperglycemia. The most significant reason for the 
variation may be due to different method of NO measurement where, the above 
mentioned studies measured NO production by isolated NO meters. However, in the 
current  study fluorometry a more sensititve method to measure oxidized product of  NO, 
nitrite an  indicator direct NO production  was utilized and confirmed by the 
immunoflouresence technique using the dye DAF-FM Diacetate. Cosentino et al. have 
reported a significant increase in NO production in aortic endothelial cells exposed to 
high glucose for 5 day using flurometric nitrite measurment method (Cosentino et al., 
1997) which is similar to our findings. Therfore, the results of the present study could be 
justified. 
Gene and protein expression analysis of PI3K/Akt pathway. This this study it 
demonstrates a slight increase but insignificant elevation of IRS-1 and IRS-2 genes 
expression in hyperglycemic condition compared to the basal control condition, while 
gene expression of PI3K, Akt and eNOS were significantly elevated in the presence of 
high glucose. Insulin treatment caused an up regulation of IRS-1 and IRS-2 genes after 1 
hour however, PI3K, Akt and eNOS were significantly reduced. Confirming the gene 
expression, western blot revealed no significant change in the lysate protein expression of 
IRS-1 in 24hrs HG exposed cells, 10mins, 1hrs and 2hrs insulin treated cell. However, 
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significant increase in IRS-1 protein expression was evident in 24hrs HG cell treated with 
insulin for 4hrs. These results are consistent with previous in vivo studies on rat retinal 
cells exposed to high glucose for 5 days and 100nM insulin treatment. They reported that 
diabetic rats had elevated basal PI3K and down regulated IRS-2. However, consistent 
with the western blot results of this study the IRS-1 protein level remains unchanged 
compared to basal control group . They report a significant restoration of IRS-1 protein 
expression upon insulin treatment a result consistent with the findings of this study 
(Reiter et al., 2006). Reiter et al. study reported that the protein analysis of the PI3K/Akt 
signaling pathway however, in the current study similar pattern of result had been also 
shown at the gene expression as well, where the gene expression of PI3K were 
upregulated with no significant change in IRS-1 expression. The protein expression of 
IRS-1 showed increased expression after 4 hours insulin treatment. The variation is some 
results such as reported earlier the current study showed reduced Akt expression followed 
by restoration after insulin treatment could be due to difference in the tissue type, varied 
duration of experimental hyperglycemia and because the gene expression are noted to 
different to protein expression.  This study also reports a significant elevation in IRS-2 
and eNOS gene expression in control group exposed to insulin treatment suggesting that 
insulin to be a positive regulator of PI3K/Akt signaling. However, further investigation 
needs to be done to investigate the effect of insulin on normal and hypoglycemic cell to 
prove the finding. 
The analysis of angiogenic and proapoptotic markers VEGFA and NFkB by RT-
PCR showed no significant change in the expression of NFkB in hyperglycemic alone, 
hyperglycemic and normoglycemic cells with insulin treatment at all-time points. 
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However, hyperglycemia significantly increased the expression of VEGF. Though 
compared to basal control group insulin treatment significantly increased the expression 
of VEGFA in both hyperglycemic and normoglycemic cells yet the expression was low 
compared to HG state at both gene and protein levels. Consistent with the VEGFA gene 
expression HG significantly increased the increase the cell migration and angiogenesis 
while insulin treatment significantly improves barrier function. Consistent with the study 
done on bovine retinal endothelial cell (Wu et al., 2010) , this study found that the 
combined effect of glucose and insulin was weaker than that of the glucose alone .  
Previous studies suggest that PI3K inhibitors  inhibit insulin-induced VEGF 
expression(Wu et al., 2010). In this study, the results are consistent with earlier studies as 
stated earlier high glucose and insulin resistance inhibits insulin induced PI3K , eNOS 
expression thereby inhibiting the insulin-stimulated PI3K insulin signaling pathway and 
nitric oxide production in HRMECs. Therefore, it can be proposed that high glucose 
could inhibit insulin-induced VEGF expression through impaired PI3K signaling 
pathway. 
Hyperglycemia significantly increases adhesion protein P-selectin with significant 
reduction at 4hrs insulin treatment. Increased adhesion molecules are reported to increase 
endothelial dysfunction  and progress towards the pathogenesis of DR. Previous studies 
have effectively proven the increased expression of adhesion protein P-selectin and 
ICAM in DR patient (Kamiuchi et al., 2002; Penman et al., 2015). However, this study 
also demonstrated a significant reduction in P-selectin after insulin suggesting that insulin 
could participate in preventing leukocyte adhesion thereby attenuating the progression of 
DR. This study could not demonstrate significance change in the ICAM-1 protein. This 
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could be due to difference in the endothelial cells used, the duration and the type of 
insulin treatment used.   
This study reported that short acting insulin commonly used in the treatment of DR could 
control the metabolic fluxes thereby leading to improvement in oxidative stress and 
apoptosis. This could prevent early changes in vasodilator, adhesion and angiogenic 
markers such as NO, VEGFA, P-selectin involved in the angiogenesis, inflammation and 
neovascularization.  
In conclusion, this study demonstrated that Hyperglycemia causes an increase in 
ROS/oxidative stress and apoptosis, while insulin promotes a significant decrease in ROS 
and apoptosis, eNOS mediated NO production increases with hyperglycemia but 
remarkably decreases with insulin treatment after 1hour, 2 hours and 4 hours, insulin 
could counteract the hyperglycemic effect on AKT/pI3 kinase which mediates NO 
production and VEGF-A, decreased adhesion molecules p-selectin involved in barrier 
disorder of retinal endothelial cells. Thus it could be proposed that insulin could be 
considered as regulators of angiogenesis.  
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4.2 SUMMARY OF DISCUSSION 
The current study depicts the association between insulin treatment and reduction in neovascularization/angiogenesis thereby, a 
proposed effective treatment for improving diabetic retinopathy. 
 
 
 
 
 
 
 
 
 
Figure4.1: Summary of discussion. Insulin as proposed negative regulator of angiogenesis. 
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4.3 CONCLUSION 
The study shows the potent effect of short-acting insulin treatment  to counteract many 
biomarkers and factors involved in the pathogenesis of DR and conserving microvascular 
function in HRECs exposed to hyperglycemia (30mM) and identifies several key factors 
which could be mediating insulin functioning. The beneficial effects of insulin 
manifested by eliciting a number of bioactive molecules in HRECs under hyperglycemia 
conditions. These molecules operate within complex systems and include compounds 
classified as NO, angiogenic factors, reactive oxygen species, adhesion proteins and 
various cellular proteins involved in retinal vascular functioning. Thus, the diabetic 
interventions using insulin as a key therapy with others may have the potential to be 
utilized as a readily available, safe and inexpensive to protect against microvascular 
complications of DR and delay its onset. 
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4.4 FUTURE DIRECTIONS: 
Further studies are necessary to clarify the effect of insulin mediated PI3K/Akt signaling 
by comparison between normoglycemic and hypoglycemic condition in HRMECs. The 
precise mechanism of eNOS uncoupling through BH4, its consequences and impact of 
upregulated ROS on eNOS needs to be explored. Assess dose dependent activity of 
PI3K/Akt signaling  and NO production  from physiological 5nM insulin to 100nM 
pharmacological dose to compare effect at both physiological and pharmacological doses. 
Confirm PI3K/Akt signaling pathway through Immunoprecipitation of phosphorylated 
proteins (Akt, eNOS). eNOS mediated NO production by using  eNOS inhibitor L-
NAME require to be confirmed. Assessment of the effect of superoxide and NO mediated 
peroxynitrite formation needs to be confirmed. Assess the effect of SOD (superoxide 
dismutates) on ROS and NO production under hyperglycemic condition. Assess 
PI3K/Akt pathway on VEGF-A expression and vascular permeability. 
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